Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
PHAR is expected to report earnings to fall 66.23% to 10 cents per share on March 18
Q4'26
Est.
$0.10
Q3'26
Missed
by $0.03
Q2'26
Missed
by $0.04
Q1'26
Missed
by $0.08
Q4'25
Beat
by $0.02
The last earnings report on October 27 showed earnings per share of 30 cents, missing the estimate of 33 cents. With 8.20K shares outstanding, the current market capitalization sits at 869.86M.